Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Chimeric Therapeutics Ltd. has announced the issuance of 55 million unquoted equity securities, set to expire on various dates, indicating an active move in the capital markets. This development could influence the company’s stock activity on the ASX, drawing attention from investors focused on biotech innovations.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.